Avoro Capital Advisors LLC Catalyst Biosciences, Inc. Transaction History

Avoro Capital Advisors LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$9.11 - $28.88 $9.33 Million - $29.6 Million	-1,024,124 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$14.18 - $35.6 $8.85 Million - $22.2 Million	624,124 Added 156.03%	1,024,124 $26.4 Million
Q4 2017 Feb 14, 2018	BUY	$4.52 - $13.69 $1.81 Million - $5.48 Million	400,000	400,000 $5.46 Million

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Avoro Capital Advisors LLC with notifications on news.